Cash Flow Statement
Growth Metrics

AdaptHealth (AHCO) Depreciation & Amortization (CF) (2019 - 2026)

AdaptHealth has reported Depreciation & Amortization (CF) over the past 7 years, most recently at $97.5 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) rose 7.7% year-over-year to $97.5 million; the TTM value through Dec 2025 reached $381.9 million, up 4.54%, while the annual FY2025 figure was $381.9 million, 4.54% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $97.5 million at AdaptHealth, roughly flat from $97.7 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $102.3 million in Q4 2022 and troughed at $47.2 million in Q1 2021.
  • A 5-year average of $87.0 million and a median of $92.3 million in 2022 define the central range for Depreciation & Amortization (CF).
  • Biggest five-year swings in Depreciation & Amortization (CF): surged 264.03% in 2021 and later decreased 9.75% in 2023.
  • Year by year, Depreciation & Amortization (CF) stood at $77.2 million in 2021, then soared by 32.52% to $102.3 million in 2022, then dropped by 9.75% to $92.4 million in 2023, then fell by 1.98% to $90.5 million in 2024, then increased by 7.7% to $97.5 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for AHCO at $97.5 million in Q4 2025, $97.7 million in Q3 2025, and $92.4 million in Q2 2025.